Free shipping on all orders over $ 500

Balixafortide

Cat. No. M27720

All AbMole products are for research use only, cannot be used for human consumption.

Balixafortide Structure
Synonym:

POL6326

Size Price Availability Quantity
5mg USD 170 In stock
10mg USD 300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects.

Chemical Information
Molecular Weight 1864.14
Formula C84H118N24O21S2
CAS Number 1051366-32-5
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Tyler Robinson, et al. Prostate. A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis

[2] Gokhan Batur, et al. Chimia (Aarau). Macrocycle Therapeutics to Treat Life-threatening Diseases

[3] Miao Miao, et al. Expert Opin Drug Metab Toxicol. Clinical significance of chemokine receptor antagonists

[4] Sonia Pernas, et al. Lancet Oncol. Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

[5] Darja Karpova, et al. J Transl Med. Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial

Related CXCR Products
Plerixafor (AMD3100)

Plerixafor (AMD3100) is a CXCR4 chemokine receptor antagonist.

WZ 811

WZ811 is a highly competitive CXCR4 antagonist with oral activity. WZ811 effectively inhibited CXCR4/SDF-1 (also known as CXCL12) -mediated regulation of cAMP level (EC50=1.2 nM) and SDF-1-induced matrix glue invasion (EC50=5.2 nM) in cells.

Navarixin

Navarixin (SCH 527123) is a novel, selective CXCR2 receptor antagonist with IC50 of 3 nM. Navarixin (SCH 527123) has Kd values of 41 nM for cynomolgus CXCR1 and 0.20 nM, 0.20 nM, 0.08 nM for mouse, rat and cynomolgus monkey CXCR2, respectivelly.

AMD3465 hexahydrobromide (AMD3465 )

AMD3465 hexahydrobromide(AMD3465 ) is an effective CXCR4 antagonist that inhibits 12G5 mAb in SupT1 cells. The IC50 values of CXCL12AF647 and CXCR4 were 0.75 nM and 18 nM, respectively. AMD 3465 also effectively inhibited X4 HIV replication (IC50, 1-10 nM), but not R5 HIV replication.

Plerixafor 8HCl

Plerixafor 8HCl (AMD3100 8HCl) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Balixafortide, POL6326 supplier, CXCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.